Group One Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Group One Trading’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,300	Closed	-$906K	–	8531
2022 Q3	$906K	Buy	13,300 +11,400	+600%	+$629K	﹤0.01%	2671
2022 Q2	$61K	Sell	1,900 -9,300	-83%	-$272K	﹤0.01%	5409
2022 Q1	$388K	Sell	11,200 -29,800	-73%	-$891K	﹤0.01%	4093
2021 Q4	$1.2M	Buy	41,000 +1,900	+5%	+$58.9K	﹤0.01%	3168
2021 Q3	$996K	Buy	39,100 +18,800	+93%	+$553K	﹤0.01%	3419
2021 Q2	$711K	Sell	20,300 -67,300	-77%	-$2.63M	﹤0.01%	3817
2021 Q1	$3.57M	Sell	87,600 -154,700	-64%	-$7.11M	0.01%	1857
2020 Q4	$10.5M	Buy	242,300 +159,000	+191%	+$7.84M	0.02%	783
2020 Q3	$4.59M	Buy	83,300 +18,900	+29%	+$1.2M	0.01%	978
2020 Q2	$4.07M	Sell	64,400 -59,300	-48%	-$4.07M	0.02%	952
2020 Q1	$6.32M	Buy	123,700 +65,900	+114%	+$4.41M	0.05%	426
2019 Q4	$4.59M	Buy	57,800 +24,600	+74%	+$1.46M	0.03%	751
2019 Q3	$1.61M	Sell	33,200 -64,400	-66%	-$3.36M	0.01%	1378
2019 Q2	$5.13M	Buy	97,600 +90,100	+1,201%	+$5.18M	0.05%	504
2019 Q1	$397K	Sell	7,500 -60,000	-89%	-$2.95M	﹤0.01%	2133
2018 Q4	$2.77M	Sell	67,500 -19,200	-22%	-$719K	0.02%	817
2018 Q3	$3.29M	Sell	86,700 -45,900	-35%	-$2.03M	0.03%	826
2018 Q2	$5.99M	Buy	132,600 +77,900	+142%	+$3.55M	0.05%	457
2018 Q1	$2.64M	Sell	54,700 -74,000	-57%	-$4.13M	0.03%	812
2017 Q4	$5.06M	Buy	128,700 +116,400	+946%	+$4.35M	0.04%	635
2017 Q3	$382K	Sell	12,300 -4,200	-25%	-$118K	﹤0.01%	2284
2017 Q2	$451K	Sell	16,500 -400	-2%	-$11.9K	﹤0.01%	2046
2017 Q1	$623K	Buy	16,900 +6,700	+66%	+$169K	0.01%	1696
2016 Q4	$147K	Buy	+10,200	New	+$179K	﹤0.01%	2611
2016 Q3	–	Sell	-500	Closed	-$8K	–	5032
2016 Q2	$8K	Buy	+500	New	+$10.1K	﹤0.01%	4156

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's GBT Position: Q2 2022 in Review

Group One Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 9,656 shares — an estimated $283K sold.

Group One Trading first reported a position in GBT in Q1 2016 and held it in 18 quarters. The position peaked at $5.54M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

Group One Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Group One Trading sold 9,656 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $283K.
Group One Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 18 quarters.
Group One Trading's Global Blood Therapeutics, Inc. position peaked at $5.54M in Q4 2020.
195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.